Last reviewed · How we verify
Metformin and Sulfonylurea — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Metformin and Sulfonylurea (Metformin and Sulfonylurea) — PhaseBio Pharmaceuticals Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Metformin and Sulfonylurea TARGET | Metformin and Sulfonylurea | PhaseBio Pharmaceuticals Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Metformin and Sulfonylurea CI watch — RSS
- Metformin and Sulfonylurea CI watch — Atom
- Metformin and Sulfonylurea CI watch — JSON
- Metformin and Sulfonylurea alone — RSS
Cite this brief
Drug Landscape (2026). Metformin and Sulfonylurea — Competitive Intelligence Brief. https://druglandscape.com/ci/metformin-and-sulfonylurea. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab